Total Assets: The sum of all assets on a company's balance sheet.
Nurix Therapeutics, Inc. (NRIX) had Total Assets of $688.13M for the most recently reported fiscal year, ending 2025-11-30.
| Income Statement Financials | |
$83.98M |
|
$-264.46M |
|
-- |
|
$83.98M |
|
$369.65M |
|
$-285.67M |
|
$21.97M |
|
$-263.70M |
|
$-263.70M |
|
$-264.46M |
|
$-264.46M |
|
$-264.46M |
|
$-264.46M |
|
$-285.67M |
|
$-277.13M |
|
86.67M |
|
86.67M |
|
$-3.05 |
|
$-3.05 |
|
| Balance Sheet Financials | |
$606.82M |
|
$22.49M |
|
$81.32M |
|
|
Total Assets |
$688.13M |
$86.47M |
|
-- |
|
$62.92M |
|
$149.39M |
|
$538.75M |
|
$538.75M |
|
$538.75M |
|
101.81M |
|
| Cash Flow Statement Financials | |
$-249.47M |
|
$147.85M |
|
$238.64M |
|
$110.90M |
|
$247.93M |
|
$137.03M |
|
$37.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-340.16% |
|
-340.16% |
|
-330.00% |
|
-314.00% |
|
-314.90% |
|
$-263.47M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-49.09% |
|
-49.09% |
|
-38.43% |
|
-49.09% |
|
$5.29 |
|
$-3.04 |
|
$-2.88 |
|